Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years

Asthma affects more than 300 million people in the world, costs over $80 billion annually in the United States, and is efficaciously treated with inhaled corticosteroids (ICS). To our knowledge, no studies have examined the real-world effectiveness of ICS, including the combination therapy consistin...

Descripción completa

Detalles Bibliográficos
Autores principales: McGeachie, Michael J., Wang, Alberta L., Lutz, Sharon M., Sordillo, Joanne E., Weiss, Scott T., Tantisira, Kelan G., Iribarren, Carlos, Lu, Meng X., Wu, Ann Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141292/
https://www.ncbi.nlm.nih.gov/pubmed/32197337
http://dx.doi.org/10.3390/jcm9030819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141292/
https://www.ncbi.nlm.nih.gov/pubmed/32197337
http://dx.doi.org/10.3390/jcm9030819

Ejemplares similares